Document Classification

Section Type: RESULTS

Text: Compared with sensor-augmented pump therapy, CLC improved significantly time spent between 80 and 140mg/dL (54. 5 % vs. 32. 2 % ; P < 0. 001) and between 70 and 180mg/dL (85. 4 % vs. 59. 1 % ; P < 0. 001) ; CLC reduced the mean glucose level at 07:00 h (119. 3 vs. 152. 9 mg/dL ; P < 0. 001) and overnight mean glucose level (139. 0 vs. 170. 3 mg/dL ; P < 0. 001) using a marginally lower amount of insulin (6. 1 vs. 6. 8 units ; P = 0. 1).